Drug eruption: Assessment of causality;Imputabilite medicamenteuse en pratique dermatologique quotidienne

Annales de Dermatologie et de Venereologie

Volumn 127, Issue 5, 2000, Pages 542-545

  Bachot, N ^a   Roujeau, J C ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOPENICILLIN; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHLOROQUINE; CYCLINE; DAPSONE; LITHIUM; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PENICILLIN DERIVATIVE; PIROXICAM; SULFANILAMIDE; TIOPRONIN; DRUG;

ARTICLE; DRUG ERUPTION; FRANCE; HUMAN; PUBLIC HEALTH; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; URTICARIA; ADULT; BACTERIAL SKIN DISEASE; CHILD; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; POLYPHARMACY; RISK FACTOR; SKIN; SKIN TEST;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG MONITORING; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; RISK FACTORS; SKIN; SKIN DISEASES, BACTERIAL; SKIN TESTS;

EID: 0033933711     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medecine. Br J Clin Pharmacol 1998;45:301-8.
2. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CMDH) : adverse skin reactions, a 20-year survey. Allergy 1997;52:388-93.
3. Roujeau JC, Stern RS. Serious adverse cutaneous reactions to drugs. N Engl J Med 1994; 331:1272-85.
4. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991;127:1333-8.
5. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
6. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments, actualisation de la méthode utilisée en France. Therapie 1985;40:111-8.
7. Putterman C, Rahav G, Shalit M, Rubinow A. « Treating through » hypersensitivity to cotrimoxazole in AIDS patients. Lancet 1990;ii :52.
8. Barbaud A, Reichert-Penetrat S, Tréchot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
9. Picketty C, Gilquin J, Kazatchkine MD. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patient. J Infect Dis 1995;172:611.